• Stem Cell Therapy CAP-1002 Shows Promise in Treating DMD-linked Heart Disease
  • Resolaris Improves Muscle Strength, Quality of Life in FSHD Patients, Study Finds
  • DMD Therapy DS-5141b Wins Japanese SAKIGAKE Fast-Track Designation
  • Emflaza, DMD Treatment, May Soon Be Available in U.S. via PTC Therapeutics
  • Diagnosis of Muscular Dystrophies May Improve with RNA Sequencing, Study Shows
  • Oral Feeding in DMD Patients Can Be Maintained by Assisted Coughing, Study Suggests
  • Heart, Other Muscles’ Response to Energy Malfunctions Has Implications for MS
  • CRISPR-Cpf1 Corrects Duchenne Mutations, Restores Dystrophin Expression, UT Study Shows
  • Bristol-Myers Squibb in Deals with Biogen, Roche to License Potential Therapies for Progressive Supranuclear Palsy, Duchenne
  • Families of Boys with DMD Donate $100,000 to Research New Therapies
  • Researchers Identify Protein with Crucial Role in Muscle Formation
  • Duchenne Muscular Dystrophy Bill SB 643 Passes California Senate Health Committee By 8-0 Vote